Home/Filings/4/0000950170-24-114788

4//SEC Filing

SCHULMAN AMY W 4

Accession 0000950170-24-114788

CIK 0001736730other

View on SEC.gov Company Profile

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 6:00 PM ET

Size

32.3 KB

Accession

0000950170-24-114788

Insider Transaction Report

Form 4

Period: 2024-10-15

Camp4 Therapeutics CorpCAMP

Polaris Management Co. VII, L.L.C.

10% Owner

Transactions

Conversion
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total(indirect: See Footnote)
→ Common Stock (1,250,061 underlying)
Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 909,090 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+1,250,061→ 1,250,061 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+353,718→ 1,603,779 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+24,745→ 112,193 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+87,448→ 87,448 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total(indirect: See Footnote)
→ Common Stock (353,718 underlying)
Conversion
Series B Preferred Stock
2024-10-15−277,536→ 0 total(indirect: See Footnote)
→ Common Stock (24,745 underlying)
Conversion
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total(indirect: See Footnote)
→ Common Stock (87,448 underlying)

Polaris Entrepreneurs' Fund VII, L.P.

10% Owner

Transactions

Conversion
Common Stock
2024-10-15+24,745→ 112,193 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+1,250,061→ 1,250,061 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total(indirect: See Footnote)
→ Common Stock (353,718 underlying)
Conversion
Common Stock
2024-10-15+87,448→ 87,448 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total(indirect: See Footnote)
→ Common Stock (1,250,061 underlying)
Conversion
Series B Preferred Stock
2024-10-15−277,536→ 0 total(indirect: See Footnote)
→ Common Stock (24,745 underlying)
Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 909,090 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+353,718→ 1,603,779 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total(indirect: See Footnote)
→ Common Stock (87,448 underlying)

Polaris Partners X, L.P.

10% Owner

Transactions

Conversion
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total(indirect: See Footnote)
→ Common Stock (353,718 underlying)
Conversion
Series B Preferred Stock
2024-10-15−277,536→ 0 total(indirect: See Footnote)
→ Common Stock (24,745 underlying)
Conversion
Common Stock
2024-10-15+87,448→ 87,448 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+1,250,061→ 1,250,061 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+353,718→ 1,603,779 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+24,745→ 112,193 total(indirect: See footnote)
Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 909,090 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total(indirect: See Footnote)
→ Common Stock (1,250,061 underlying)
Conversion
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total(indirect: See Footnote)
→ Common Stock (87,448 underlying)

Polaris Partners VII, L.P.

10% Owner

Transactions

Conversion
Common Stock
2024-10-15+353,718→ 1,603,779 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total(indirect: See Footnote)
→ Common Stock (353,718 underlying)
Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 909,090 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+1,250,061→ 1,250,061 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+87,448→ 87,448 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total(indirect: See Footnote)
→ Common Stock (87,448 underlying)
Conversion
Common Stock
2024-10-15+24,745→ 112,193 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total(indirect: See Footnote)
→ Common Stock (1,250,061 underlying)
Conversion
Series B Preferred Stock
2024-10-15−277,536→ 0 total(indirect: See Footnote)
→ Common Stock (24,745 underlying)

Polaris Partners GP X, L.L.C.

10% Owner

Transactions

Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 909,090 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+24,745→ 112,193 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+1,250,061→ 1,250,061 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+353,718→ 1,603,779 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+87,448→ 87,448 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total(indirect: See Footnote)
→ Common Stock (1,250,061 underlying)
Conversion
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total(indirect: See Footnote)
→ Common Stock (87,448 underlying)
Conversion
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total(indirect: See Footnote)
→ Common Stock (353,718 underlying)
Conversion
Series B Preferred Stock
2024-10-15−277,536→ 0 total(indirect: See Footnote)
→ Common Stock (24,745 underlying)

SCHULMAN AMY W

10% Owner

Transactions

Conversion
Common Stock
2024-10-15+1,250,061→ 1,250,061 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+353,718→ 1,603,779 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−14,020,475→ 0 total(indirect: See Footnote)
→ Common Stock (1,250,061 underlying)
Conversion
Series B Preferred Stock
2024-10-15−3,967,234→ 0 total(indirect: See Footnote)
→ Common Stock (353,718 underlying)
Conversion
Common Stock
2024-10-15+87,448→ 87,448 total(indirect: See footnote)
Conversion
Common Stock
2024-10-15+24,745→ 112,193 total(indirect: See footnote)
Conversion
Series A Prime Preferred Stock
2024-10-15−980,829→ 0 total(indirect: See Footnote)
→ Common Stock (87,448 underlying)
Conversion
Series B Preferred Stock
2024-10-15−277,536→ 0 total(indirect: See Footnote)
→ Common Stock (24,745 underlying)
Purchase
Common Stock
2024-10-15$11.00/sh+909,090$9,999,990→ 909,090 total(indirect: See footnote)

Footnotes (5)

[F1]On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
[F2]The reported securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of David Barrett, Brian Chee, Amir Nashat, a member of the Issuer's board of directors, and Bryce Youngren (collectively, the "PMC VII Managing Members") are the managing members of PMC VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
[F3]The reported securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PEF VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
[F4]On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
[F5]The reported securities are owned directly by Polaris Partners X, L.P. ("PP X"). Polaris Partners GP X, L.L.C. ("PPGP X") is the general partner of PP X. Each of Amy Schulman and Brian Chee are the managing members of PPGP X (the "PPGP X Managing Members"). Amir Nashat ("Mr. Nashat"), a member of the Issuer's board of directors, is an interest holder of PPGP X. Each of PPGP X, the PPGP X Managing Members and Mr. Nashat, in their respective capacities with respect to PPGP X, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP X. Each of PPGP X, the PPGP X Managing Members and Mr. Nashat disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PPGP X Managing Members, Mr. Nashat or PPGP X is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

→

Entity typeother

Related Parties

filerCIK 0001438226

Filing Metadata

Form type: 4
Filed: Oct 14, 8:00 PM ET
Accepted: Oct 15, 6:00 PM ET
Size: 32.3 KB

View on SEC.gov